Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://amaanyguq612595.answerblogs.com/39351642/semaglutide-a-potential-solution-for-metabolic-disorders